| Literature DB >> 35645353 |
Paola Bisceglia1, Filomena Lo Vecchio1, Raffaela Rita Latino2, Carolina Gravina1, Maria Urbano1, Annamaria la Torre1, Gaetano Desina3, Antonio Greco1, Maurizio Leone2, Annibale Antonioni4.
Abstract
Alzheimer's disease (AD) is the most common cause of dementia worldwide. The clinical spectrum of suspected AD has been extended from mild cognitive impairment (MCI) to preclinical AD which includes people who have typical cognitive function but harbor the underlying biological features of AD. We report the first case of an Italian patient affected by MCI (MMSE 24\30), characterized by a double mutation p.Lys311Arg (K311R) and p.Glu318Gly (E318G) in Presenilin-1 but with the absence of abnormal accumulation of amyloid beta.Entities:
Keywords: Alzheimer’s disease; PSEN1; apolipoprotein E; beta-amyloid; mild cognitive impairment
Year: 2022 PMID: 35645353 PMCID: PMC9149895 DOI: 10.3390/neurolint14020034
Source DB: PubMed Journal: Neurol Int ISSN: 2035-8385